Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38489858

Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2024 May
First author
Raiser P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Raiser P
      type
      Author
    2. name
      Schleiermacher G
      type
      Author
    3. name
      Gambart M
      type
      Author
    4. name
      Dumont B
      type
      Author
    5. name
      Defachelles AS
      type
      Author
    6. name
      Thebaud E
      type
      Author
    7. name
      Tandonnet J
      type
      Author
    8. name
      Pasqualini C
      type
      Author
    9. name
      Proust S
      type
      Author
    10. name
      Entz-Werle N
      type
      Author
    11. name
      Aerts I
      type
      Author
    12. name
      Ndounga-Diakou LA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Raiser P
      type
      Author
    2. name
      Schleiermacher G
      type
      Author
    3. name
      Gambart M
      type
      Author
    4. name
      Dumont B
      type
      Author
    5. name
      Defachelles AS
      type
      Author
    6. name
      Thebaud E
      type
      Author
    7. name
      Tandonnet J
      type
      Author
    8. name
      Pasqualini C
      type
      Author
    9. name
      Proust S
      type
      Author
    10. name
      Entz-Werle N
      type
      Author
    11. name
      Aerts I
      type
      Author
    12. name
      Ndounga-Diakou LA
      type
      Author
    bibliography ids
    1. nci-bib-5e55defa94d7697fa35ee283
    book metadata
    content sha256
    900a581f9383f58c0415a4a8dcc9bc790881d8554f1da62c5576fe13782bd601
    document type
    citation
    dois
    1. 10.1016/j.ejca.2024.114001
    electronic publication date
    display
    2024 Mar 11
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38489858
    immutable id
    pubmed:38489858@900a581f9383f58c0415a4a8dcc9bc790881d8554f1da62c5576fe13782bd601
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    Source null
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    114001
    volume
    202
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38489858
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      6a4626b28fa47f71d944e41038bd3e0b96f272fce88fea741dce38c48f457dc7
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 May
      precision
      month
      year
      2024
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38489858/
      title
      Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

      Preserved source evidence · Not medical advice